Summary

Market Overview
The Global Stent Market was valued at USD 15.04 Billion in 2024 and is projected to reach USD 34.75 Billion by 2030, growing at a CAGR of 4.38%. Stents are small mesh tubes used to reinforce narrowed or weakened arteries, playing a critical role in managing cardiovascular and vascular conditions such as coronary artery disease and peripheral artery disease. The market is expanding due to the increasing prevalence of lifestyle-related health conditions—such as diabetes, hypertension, and obesity—that heighten the risk of arterial blockages. With a rising geriatric population and the global shift toward sedentary lifestyles, the demand for stenting procedures continues to grow. This surge is evident in both developed countries with aging demographics and emerging markets experiencing rapid urbanization and healthcare evolution. However, the market faces hurdles including the high cost of advanced stent technologies, especially in resource-limited settings, and regulatory complexities that may slow the adoption of newer innovations.
Key Market Drivers
Growth in Healthcare Industry
The expansion of the global healthcare sector, which generates over USD 4 trillion annually, is significantly influencing the growth of the stent market. Key segments such as pharmaceuticals, biotechnology, medical technology, and diagnostics contribute hundreds of billions in revenue and are central to the rising demand for advanced treatment solutions. As investments in healthcare infrastructure increase worldwide, so does access to cutting-edge cardiovascular care. Public and private healthcare spending has enabled better-equipped hospitals, improved interventional cardiology services, and wider availability of diagnostic tools. Cardiovascular diseases, responsible for around 17.9 million deaths globally each year, remain the leading cause of mortality. Over 80% of these are due to heart attacks and strokes, with nearly one-third of cases occurring prematurely in people under 70. Stents are a standard component in the treatment of these conditions, particularly in angioplasty procedures. The adoption of advanced technologies and minimally invasive interventions has contributed to the widespread use of stents in both high-income and developing nations.
Key Market Challenges
Limited Accessibility of Stents
Limited accessibility to stents poses a significant challenge, particularly in low- and middle-income regions. Although technological advancements have made stent procedures more effective and less invasive, access remains uneven. Many patients in under-resourced areas encounter financial and infrastructural barriers that prevent them from receiving timely and effective treatment. A primary constraint is the high cost associated with advanced stents, including drug-eluting and bioabsorbable variants, which often exceed the budget of public healthcare systems in these regions. Costs extend beyond the devices themselves to include diagnostics, surgery, hospitalization, and post-operative care. In countries where insurance coverage is limited and public subsidies are scarce, patients are frequently left with few options—either forgoing treatment or settling for outdated or substandard alternatives.
Key Market Trends
Growing Development of 3D-Printed Stents
The development of 3D-printed stents marks a significant innovation in the stent market, driven by the need for personalized treatment and advancements in additive manufacturing. Unlike traditional stents, which come in standardized forms, 3D printing allows for custom-designed stents tailored to a patient’s exact anatomical structure. This customization leads to improved placement accuracy, better clinical outcomes, and fewer complications such as restenosis or stent malapposition. A notable example includes patient-specific stents created at the Cleveland Clinic using CT imaging and proprietary 3D visualization software, where 3D-printed molds are used to shape medical-grade silicone. These personalized devices ensure a precise fit and highlight the potential of 3D printing to revolutionize cardiovascular care.
Key Market Players
• Medtronic plc
• B. Braun Melsungen AG
• Terumo Corporation
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina GmbH
• Biosensors International Group Limited
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
Report Scope
In this report, the Global Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Stent Market, By Product Type:
o Drug-Eluting Stent
o Bare Metal Coronary Stent
o Bioabsorbable Stent
o Others
• Stent Market, By End Use:
o Hospitals & Clinics
o Ambulatory Surgical Centers
o Others
• Stent Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Stent Market.
Available Customizations
Global Stent Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Stent Market
5. Global Stent Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, Bioabsorbable Stent, Others)
5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Stent Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Stent Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By End Use
6.3.2. Mexico Stent Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By End Use
6.3.3. Canada Stent Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By End Use
7. Europe Stent Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Stent Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By End Use
7.3.2. Germany Stent Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By End Use
7.3.3. United Kingdom Stent Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By End Use
7.3.4. Italy Stent Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By End Use
7.3.5. Spain Stent Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By End Use
8. Asia Pacific Stent Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Stent Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By End Use
8.3.2. India Stent Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By End Use
8.3.3. South Korea Stent Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By End Use
8.3.4. Japan Stent Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By End Use
8.3.5. Australia Stent Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By End Use
9. South America Stent Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Stent Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By End Use
9.3.2. Argentina Stent Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By End Use
9.3.3. Colombia Stent Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By End Use
10. Middle East and Africa Stent Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Stent Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Stent Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By End Use
10.3.3. UAE Stent Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions : Conflicts, Pandemics and Trade Barriers
14. Global Stent Market: SWOT Analysis
15. Porters Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Medtronic plc
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. B. Braun Melsungen AG
16.3. Terumo Corporation
16.4. STENTYS SA
16.5. MicroPort Scientific Corporation
16.6. Meril Life Sciences Pvt. Ltd
16.7. Translumina GmbH
16.8. Biosensors International Group Limited
16.9. Boston Scientific Corporation
16.10. BIOTRONIK SE & Co. KG
17. Strategic Recommendations
18. About Us & Disclaimer